Recovery of gastric function after Helicobacter pylori eradication in subjects with body atrophic gastritis:: Prospective 4-year study

被引:7
作者
Di Mario, F
Moussa, AM
Dal Bò, ND
Caruana, P
Pilotto, A
Cavallaro, LG
Cavestro, GM
Iori, V
Merli, R
Franzé, A
Rugge, M
机构
[1] Univ Parma, Dipartimento Sci Clin, I-43100 Parma, Italy
[2] Univ Parma, Pathol Unit, I-43100 Parma, Italy
[3] IRCCS, Geriatr Unit, San Giovanni Rotondo, Italy
[4] Univ Padua, Pathol Unit, I-35100 Padua, Italy
[5] Gastroenterol & Endoscopy Unit, Parma, Italy
关键词
eradication therapy; Helicobacter pylori related-atrophic body gastritis; serum pepsinogen I;
D O I
10.1111/j.1440-1746.2005.04051.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The relationship between Helicobacter pylori (H. pylori) eradication and atrophic changes in the gastric mucosa has not yet been fully defined. Although studies report a partial restoration of serum pepsinogen I (sPGI) levels after eradication, it is not clear if this finding reflects gastric mucosal healing on a morphological level. Aim: To assess alterations in gastric function after H. pylori eradication on moderate/severe body atrophic gastritis by determination of sPGI levels. Methods: Twenty-three dyspeptic patients, selected from 284 consecutive H. pylori positive patients, with histological features of moderate/severe body atrophic gastritis and sPGI < 25 mu g/L (11 men, mean age: 51.8 years, range: 29-79 years), underwent an upper gastrointestinal endoscopy with gastric biopsies and sPGI determination at baseline. All patients underwent eradication therapy. Serum pepsinogen I was measured again after 6 months, and at 1, 2, 3 and 4 years after eradication therapy. Results: Mean sPGI levels prior to eradication were 11.9 mu g/L (range: 4-23 mu g/L). Six months after eradication therapy, mean sPGI levels significantly increased to 17.4 mu g/L (P = 0.04). At the completion of the study, 4 years after eradication, sPGI levels increased from 17.4 to 32.7 mu g/L (P = 0.01). A significant progressive increase in sPGI levels was observed from 6 months to 1 year (17.4 to 23.9 mu g/L) and from 1 to 2 years (23.9 to 26.0 mu g/L, P = 0.01). Serum pepsinogen I levels higher than the cut-off value of 25 mu g/L were observed at various time-points: 6.3% of patients at 6 months (1/16), 33.3% (5/15) at 1 year, 50% (7/14) at 24 months, 66.7% (6/9) at 36 months and 87.5% (7/8) at 4 years. Conclusion: After H. pylori eradication, subjects with body atrophic gastritis showed long-term improvement of physiological gastric function, reflected by significantly and continually increasing sPGI levels over a 4-year period. (C) 2005 Blackwell Publishing Asia Pty Ltd.
引用
收藏
页码:1661 / 1666
页数:6
相关论文
共 54 条
  • [1] Atrophic body gastritis: Distinct features associated with Helicobacter pylori infection
    Annibale, B
    Marignani, M
    Azzoni, C
    DAmbra, G
    Caruana, P
    DAdda, T
    DelleFave, G
    Bordi, C
    [J]. HELICOBACTER, 1997, 2 (02) : 57 - 64
  • [2] The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis
    Annibale, B
    Di Giulio, E
    Caruana, P
    Lahner, E
    Capurso, G
    Bordi, C
    Delle Fave, G
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (10) : 1723 - 1731
  • [3] Relationship between Helicobacter pylori, gastric parietal cell antibodies and heat shock proteins
    Asante, MA
    Mendall, MA
    Ballam, L
    Morris, J
    Northfield, TC
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1999, 11 (12) : 1365 - 1370
  • [4] Ciok J, 1997, J Physiol Pharmacol, V48 Suppl 4, P115
  • [5] QUANTITATIVE ASSESSMENT OF HISTOLOGICAL-CHANGES IN CHRONIC GASTRITIS AFTER ERADICATION OF HELICOBACTER-PYLORI
    DINAPOLI, A
    PETRINO, R
    BOERO, M
    BELLIS, D
    CHIANDUSSI, L
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1992, 45 (09) : 796 - 798
  • [6] Classification and grading of gastritis - The updated Sydney System
    Dixon, MF
    Genta, RM
    Yardley, JH
    Correa, P
    Batts, KP
    Dahms, BB
    Filipe, MI
    Haggitt, RC
    Haot, J
    Hui, PK
    Lechago, J
    Lewin, K
    Offerhaus, JA
    Price, AB
    Riddell, RH
    Sipponen, P
    Solcia, E
    Watanabe, H
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (10) : 1161 - 1181
  • [7] Increased prevalence of precancerous changes in relatives of gastric cancer patients:: Critical role of H-pylori
    El-Omar, EM
    Oien, K
    Murray, LS
    El-Nujumi, A
    Wirz, A
    Gillen, D
    Williams, C
    Fullarton, G
    McColl, KEL
    [J]. GASTROENTEROLOGY, 2000, 118 (01) : 22 - 30
  • [8] Helicobacter pylori infection and chronic gastric acid hyposecretion
    ElOmar, EM
    Oien, K
    ElNujumi, A
    Gillen, D
    Wirz, A
    Dahill, S
    Williams, C
    Ardill, JES
    McColl, KEL
    [J]. GASTROENTEROLOGY, 1997, 113 (01) : 15 - 24
  • [9] Long-term follow-up of gastric histology after Helicobacter pylori eradication
    Forbes, GM
    Warren, JR
    Glaser, ME
    Cullen, DJE
    Marshall, BJ
    Collins, BJ
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1996, 11 (07) : 670 - 673
  • [10] Furuta T, 1998, SCAND J GASTROENTERO, V33, P357, DOI 10.1080/00365529850170973